Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65). (Q42911235)

11 November 2017

title

Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65). (English)

1 reference

11 November 2017

4

1 reference

11 November 2017

Stina Axelsson

1

1 reference

11 November 2017

Maria Hjorth

series ordinal

2

1 reference

11 November 2017

Linda Akerman

series ordinal

3

1 reference

11 November 2017

Rosaura Casas

series ordinal

5

1 reference

11 November 2017

publication date

1 October 2010

1 reference

Diabetes - Metabolism: Research and Reviews

11 November 2017

published in

1 reference

11 November 2017

volume

26

1 reference

11 November 2017

issue

7

1 reference

11 November 2017

page(s)

559-568

1 reference

Type I diabetes mellitus. A chronic autoimmune disease

11 November 2017

cites work

1 reference

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

The pathogenesis of insulin-dependent diabetes mellitus

21 January 2018

1 reference

7 January 2021

Factors associated with early remission of type I diabetes in children treated with cyclosporine

1 reference

7 January 2021

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

7 January 2021

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials

1 reference

7 January 2021

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

7 January 2021

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

1 reference

7 January 2021

Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?

1 reference

7 January 2021

Parameters influencing antigen-specific immunotherapy for type 1 diabetes

1 reference

7 January 2021

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

1 reference

7 January 2021

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription

1 reference

7 January 2021

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

1 reference

7 January 2021

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

7 January 2021

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy

1 reference

7 January 2021

Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results

1 reference

7 January 2021

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

1 reference

7 January 2021

Does GAD have a unique role in triggering IDDM?

1 reference

7 January 2021

Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells

1 reference

7 January 2021

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

1 reference

7 January 2021

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

7 January 2021

Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children.

1 reference

7 January 2021

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

7 January 2021

Mechanisms of foxp3+ T regulatory cell-mediated suppression

1 reference

7 January 2021

Memory and effector T cells modulate subsequently primed immune responses to unrelated antigens

1 reference

7 January 2021

CD3-specific antibody-induced active tolerance: from bench to bedside

1 reference

7 January 2021

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

1 reference

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

7 January 2021

Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens

1 reference

7 January 2021

Interferon γ: a crucial role in the function of induced regulatory T cells in vivo

1 reference

7 January 2021

T-cell quality in memory and protection: implications for vaccine design

1 reference

7 January 2021

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

7 January 2021

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

1 reference

7 January 2021

Achieving antigen-specific tolerance in diabetes: regulating specifically

1 reference

7 January 2021

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

1 reference

7 January 2021

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

1 reference

7 January 2021

Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients

1 reference

7 January 2021

Parameters influencing antigen-specific immunotherapy for Type 1 diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1126

1 reference

11 November 2017

1 reference